PetVivo Holdings (PETV) Accumulated Expenses (2018 - 2026)
PetVivo Holdings' Accumulated Expenses was $344,911 in fiscal Q1 2027 (quarter ended Jun 30, 2026), down 59.2% from $846,378 a year earlier and down 24.0% from the prior quarter.
Powered by 
Analysis
PetVivo Holdings (PETV) Accumulated Expenses (2018 - 2026) Analysis & Trends
At the end of FY2026 (ended Mar 31, 2026), Accumulated Expenses at PetVivo Holdings came in at $453,713, down 52.2% from FY2025.
- Accumulated Expenses shows a five-year compound annual growth rate of -3.9% (FY2021 to FY2026).
- In earlier fiscal years, Accumulated Expenses was $948,554 in FY2025 (+290.3%), $243,030 in FY2024 (-68.8%), $779,882 in FY2023 (-0.6%) and $784,375 in FY2022 (+41.6%).
- The fiscal Q1 2027 figure marks the lowest quarterly Accumulated Expenses since fiscal Q1 2025.
- Compared with a year earlier, Accumulated Expenses was higher in five of the last eight quarters, with growth averaging 66.1%.
- The best year-over-year quarter for Accumulated Expenses over five years was fiscal Q4 2025 (growth of 290.3%); the worst was fiscal Q3 2024 (a decline of 76.8%).
- Per Business Quant data, PETV's Accumulated Expenses in the three fiscal quarters before Q1 2027 was $453,713 (Q4 2026), $541,203 (Q3 2026) and $618,736 (Q2 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,359.75 Bn | 1,333.37 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 688.76 Bn | 608.62 Bn | 17.30 Bn |
| 3 | AbbVie | 521.69 Bn | 489.75 Bn | 13.12 Bn |
| 4 | Merck | 364.31 Bn | 327.31 Bn | 13.19 Bn |
| 5 | Novartis Ag | 306.35 Bn | 279.93 Bn | - |
| 6 | Astrazeneca | 285.96 Bn | 259.56 Bn | 13.26 Bn |
| 7 | Amgen | 251.88 Bn | 203.53 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 208.59 Bn | 183.61 Bn | 6.73 Bn |
| 9 | Pfizer | 164.73 Bn | 112.38 Bn | 12.56 Bn |
| 10 | PetVivo Holdings | 19.55 Mn | 18.29 Mn | 223,317.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 344,911.00 |
| Mar 31, 2026 | 453,713.00 |
| Dec 31, 2025 | 541,203.00 |
| Sep 30, 2025 | 618,736.00 |
| Jun 30, 2025 | 846,378.00 |
| Mar 31, 2025 | 948,554.00 |
| Dec 31, 2024 | 410,056.00 |
| Sep 30, 2024 | 395,625.00 |
| Jun 30, 2024 | 246,378.00 |
| Mar 31, 2024 | 243,030.00 |
| Dec 31, 2023 | 241,959.00 |
| Sep 30, 2023 | 818,357.00 |
| Jun 30, 2023 | 1.05 Mn |
| Mar 31, 2023 | 779,882.00 |
| Dec 31, 2022 | 1.37 Mn |
| Sep 30, 2022 | 1.10 Mn |
| Jun 30, 2022 | 1.01 Mn |
| Mar 31, 2022 | 1.12 Mn |
| Dec 31, 2021 | 1.14 Mn |
| Sep 30, 2021 | 2,031.00 |
API Access
PetVivo Holdings Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=PETV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "PETV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=PETV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();